Best Life Online

Best Life is a lifestyle website that provides timely and actionable news, advice, and entertaining stories aimed at helping readers live their best lives. The site covers topics such as health and fitness, finance, relationship issues, fashion, and grooming for men and women aged 35 and over. It also features literary writing, humor, in-depth research from expert contributors on a wide range of subjects.

63%

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

10%

Examples:

  • [author] There's no denying the impact that Ozempic and other similar medications have had over the past year. But the three new studies have concluded that all GLP-1 drugs carry a rare but consistent risk of gastroparesis. [[author]] If a patient is on a medication which is associated with gastroparesis, they can stop or change medications and their gastroparesis will likely go away. [[expert]] For the people who get this complication, it is extremely serious.
  • If a source of information has an agenda or financial ties to the subject matter, it may influence its content. In this case, there is a potential conflict of interest as David Zinczenko, the founder and CEO of Best Life, is also an author for some medications and diet books that might be mentioned in the articles.

Conflicts of Interest

90%

Examples:

  • [author] For the people who get this complication, it is extremely serious.

Contradictions

80%

Examples:

  • 㳥COVID activity is high, particularly in the eastern part of the country

Deceptions

85%

Examples:

  • COVID JN.1 Now Accounts for 86 Percent of Cases—These Are the Symptoms

Recent Articles

  • GLP-1 Agonists and Gastroparesis: Uncovering the Connection and Its Implications

    GLP-1 Agonists and Gastroparesis: Uncovering the Connection and Its Implications

    Broke On: Monday, 20 May 2024 Weight loss drugs, such as GLP-1 agonists like Ozempic and Wegovy, have been linked to an increased risk of gastroparesis. Studies suggest that 10 out of every 10,000 people taking these medications for weight loss are diagnosed with gastroparesis at least six months later compared to 4 out of every 10,000 people not taking the medication. Over fifty lawsuits have been filed against drug manufacturers due to potential side effects and lack of clear warnings about this risk.
  • COVID-19 Cases in the US: JN.1 Subvariant of Omicron Takes Over as Most Prevalent Strain, but No Evidence of More Severe Disease Compared to Other Variants

    COVID-19 Cases in the US: JN.1 Subvariant of Omicron Takes Over as Most Prevalent Strain, but No Evidence of More Severe Disease Compared to Other Variants

    Broke On: Wednesday, 31 January 2024 The US is facing a surge in COVID-19 cases due to the JN.1 subvariant of Omicron, which has evaded vaccines and treatments. However, early data shows that it does not cause more severe illness than previous strains. Anxiety and insomnia may be new symptoms for some individuals, but hospitalization rates are still being monitored.